Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_assertion type Assertion NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_head.
- NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_assertion description "[In the training set, PAK1 levels were associated with tumor progression after tamoxifen (HR 1.57, 95% CI 0.99-2.48), as was co-expression of PKA and ER?S305-P (HR 2.00, 95% CI 1.14-3.52).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_provenance.
- NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_assertion evidence source_evidence_literature NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_provenance.
- NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_assertion SIO_000772 20213082 NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_provenance.
- NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_assertion wasDerivedFrom befree-20140225 NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_provenance.
- NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_assertion wasGeneratedBy ECO_0000203 NP828574.RAa3Ra3Sj_nTgtyPbkca0QLGa0AruftHIzwSU4OagON8w130_provenance.